miR-4674表达变化对BGC-823胃癌细胞系生物学特征的影响

摘要/Abstract

摘要：

目的：以生物信息学研究为基础，探讨miR-4674表达变化对BGC-823胃癌细胞系生物学特征的影响。方法：通过生物信息学分析，得到与胃癌关系密切的研究靶点miR-4674，构建miR-4674模拟物（mimic）、抑制物（inhibitor）以及相关阴性对照（NC）转染至BGC-823细胞系。应用逆转录聚合酶链式反应（RT-PCR）方法检测BGC-823细胞中miR-4674的表达变化。应用噻唑蓝（MTT）法检测细胞增殖能力。应用Transwell培养体系检测细胞迁移能力，应用TUNEL检测细胞的凋亡情况。结果：与空白对照组以及转染NC的细胞比较，转染miR-4674 mimic的细胞中miR-4674表达水平明显升高，细胞的增殖与迁移能力均明显升高（P<0.05），而转染miR-4674 inhibitor的细胞中miR-4674表达水平明显降低，细胞的增殖与迁移能力均明显下降（P<0.05）。TUNEL检测结果显示，各组均未见到凋亡细胞。结论：在BGC-823胃癌细胞系抑制miR-4674表达降低其恶性程度，在BGC-823胃癌细胞系过表达miR-4674则促进其恶性程度,miR-4674可能是胃癌干预的治疗靶点，为胃癌的治疗提供了新的策略。

关键词:miR-4674,胃癌,BGC-823细胞系,恶性程度

Abstract:

ObjectiveTo explore the impact of miR-4674 expression changes on the biological characteristics of BGC-823 gastric cancer cell line based on bioinformatics research.MethodsThrough bioinformatics screening, miR-4674 was prioritized as a gastric cancer-associated miRNA. We constructed miR-4674 mimic, inhibitor, and corresponding negative control (NC) transfected into the BGC-823 cell line. Reverse transcription-polymerase chain reaction (RT-PCR) method was used to detect the expression changes of miR-4674 in BGC-823 cells. Functional assays included: MTT assay for cell proliferation ability; Transwell assay for migration capacity; TUNEL staining for cell apoptosis detection.ResultsCompared with the control group and cells transfected with NC, the level of miR-4674 was significantly increased in cells transfected with miR-4674 mimic, and the proliferation and migration abilities of the cells were significantly improved (P< 0.05). In cells transfected with miR-4674 inhibitor, the level of miR-4674 was significantly decreased, and the proliferation and migration abilities of the cells were significantly reduced (P<0.05). The result of TUNEL showed no significant differences in apoptotic rates were observed across all groups.ConclusionsIn the BGC-823 gastric cancer cell line, inhibition of miR-4674 expression can reduce its malignancy, while overexpression of miR-4674 can enhance its malignancy, suggesting its potential as a therapeutic target for gastric cancer intervention, providing a new strategy for the treatment of gastric cancer.

Key words:miR-4674,Gastric cancer,BGC-823 cell line,Malignancy degree

中图分类号:

R735.2

袁小兵, 朱建伟. miR-4674表达变化对BGC-823胃癌细胞系生物学特征的影响[J]. 外科理论与实践, 2025, 30(04): 295-301.

YUAN Xiaobing, ZHU Jianwei. Impact of miR-4674 expression changes on the biological characteristics of BGC-823 gastric cancer cell line[J]. Journal of Surgery Concepts & Practice, 2025, 30(04): 295-301.

图/表7

图1

图2

图3

图4

组别	n	迁移数量
control组	8	31.79±2.52
mimic NC组	8	35.45±2.31
inhibitor NC组	8	34.04±4.43
mimic组	8	39.98±3.53^*&@
inhibitor组	8	12.38±1.80^*&@#
F值		97.29
P值		<0.01

表1

图5

图6

参考文献16

[1]	PAWLUCZUK E, ŁUKASZEWICZ-ZAJĄC M, MROCZKO B. The comprehensive analysis of specific proteins as novel biomarkers involved in the diagnosis and progression of gastric cancer[J].Int J Mol Sci,2023,24(10):8833.
[2]	SMYTH E C, NILSSON M, GRABSCH H I, et al. Gastric cancer[J].Lancet,2020,396(10251):635-648. doi:S0140-6736(20)31288-5pmid:32861308
[3]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018 : GLOBOCAN estimates of incidence andmortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[4]	CHEN W, ZHENG R, BAADE P D, et al. Cancer statisticsin China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
[5]	FENG R M, ZONG Y N, CAO S M, et al. Current cancer situation in China: good or bad news from the 2018 clobal cancer statistics?[J].Cancer Commun(Lond),2019,39(1):22.
[6]	MATSUOKA T, YASHIRO M. Biomarkers of gastric cancer: current topics and future perspective[J].World J Gastroenterol,2018,24(26):2818-2832.
[7]	ALIX-PANABIÈRES C, PANTEL K. Liquid biopsy: from discovery to clinical application[J].Cancer Discov,2021,11(4):858-873.
[8]	YU L, XU Y, YANG J R, et al. miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cellsviablocking Wnt/β-catenin signaling pathway[J].Chin J Cell Mol Immunol,2023,39(7):617-625.
[9]	ZHAN T, CHEN M, LIU W, et al. MiR-455-3p inhibits gastric cancer progression by repressing Wnt/β-catenin signaling through binding to ARMC8[J].BMC Med Genomics,2023,16(1):155. doi:10.1186/s12920-023-01583-ypmid:37400847
[10]	BARGIELA-IPARRAGUIRRE J, HERRERO J M, PAJUELO-LOZANO N, et al. Regulatory effects of miR-19a on MAD2 expression and tumorigenesis in gastric cancer[J].Genes Dis,2023,10(4):1180-1182.
[11]	DARANG E, PEZESHKIAN Z, MIRHOSEINI S Z, et al. Bioinformatics and pathway enrichment analysis identified hub genes and potential biomarker for gastric cancer prognosis[J].Front Oncol,2023,13:1187521.
[12]	KNYAZEV E N, SAMATOV T R, FOMICHEVA K A, et al. MicroRNA hsa-miR-4674 in hemolysis-free blood plasma is associated with distant metastases of prostatic cancer[J].Bull Exp Biol Med,2016,161(1):112-115.
[13]	LIAO Q, WANG Z, CADENA S M S C. Editorial: targe-ting oxidative stress in cancer: what is new in the prevention, diagnostic, treatment and prognostic strategies?[J].Front Pharmacol,2023,14:1229785.
[14]	AZADI S, TORKASHVAND E, MOHAMMADI E, et al. Analysis of EMT induction in a non-invasive breast cancer cell line by mesenchymal stem cell supernatant: study of 2D and 3D microfluidic based aggregate formation and migration ability, and cytoskeleton remodeling[J].Life Sci,2023,320:121545.
[15]	WARDAS B, SCHNEIDER J G, KLUGBAUER N, et al. Englerin A inhibits T-type voltage-gated calcium channels at low-micromolar concentrations[J].Mol Pharmacol,2023,104(4):144-153.
[16]	GUPTA J, JALIL A T, ABD ALZAHRAA Z H, et al. The metformin immunoregulatory actions in tumor suppression and normal tissues protection[J].Curr Med Chem,2024,31(33):5370-5396.